Bank of America
FBRX icon

Bank of America’s Forte Biosciences FBRX Stock Holding History

Bank of America’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$560K Buy
21,606
+17,634
+444% +$508K ﹤0.01% 4832
2025
Q4 		$108K Buy
3,972
+814
+26% +$14.3K ﹤0.01% 5595
2025
Q3 		$47.4K Buy
3,158
+3,103
+5,642% +$35.7K ﹤0.01% 6854
2025
Q2 		$711 Buy
55
+9
+20% +$77 ﹤0.01% 7595
2025
Q1 		$357 Buy
46
+36
+360% +$425 ﹤0.01% 7580
2024
Q4 		$227 Sell
10
-13
-57% -$155 ﹤0.01% 7564
2024
Q3 		$129 Buy
23
+12
+109% +$123 ﹤0.01% 7668
2024
Q2 		$142 Buy
+11
New +$178 ﹤0.01% 7635
2024
Q1 		– Sell
-1
Closed -$17 – 7871
2023
Q4 		$17 Sell
1
-25
-96% -$349 ﹤0.01% 7680
2023
Q3 		$428 Buy
26
+21
+420% +$465 ﹤0.01% 7331
2023
Q2 		$122 Sell
5
-9
-64% -$234 ﹤0.01% 7411
2023
Q1 		$362 Buy
14
+7
+100% +$176 ﹤0.01% 7391
2022
Q4 		$163 Sell
7
-3
-30% -$77 ﹤0.01% 7586
2022
Q3 		$0 Sell
10
-49
-83% -$1.56K ﹤0.01% 7952
2022
Q2 		$2K Sell
59
-2,373
-98% -$75.4K ﹤0.01% 7777
2022
Q1 		$89K Sell
2,432
-92
-4% -$3.48K ﹤0.01% 6922
2021
Q4 		$136K Buy
2,524
+2,269
+890% +$153K ﹤0.01% 6712
2021
Q3 		$19K Buy
255
+76
+42% +$42.1K ﹤0.01% 7399
2021
Q2 		$150K Buy
179
+11
+7% +$9.91K ﹤0.01% 6278
2021
Q1 		$143K Buy
+168
New +$138K ﹤0.01% 6243
2020
Q4 		– Sell
-155
Closed -$146K – 7158
2020
Q3 		$187K Buy
155
+148
+2,114% +$98.1K ﹤0.01% 5332
2020
Q2 		$2K Buy
7
+4
+133% +$1.79K ﹤0.01% 6664
2020
Q1 		$2K Sell
3
-39
-93% -$15.2K ﹤0.01% 6630
2019
Q4 		$8K Buy
42
+1
+2% +$227 ﹤0.01% 6682
2019
Q3 		$11K Buy
41
+6
+17% +$9.11K ﹤0.01% 6706
2019
Q2 		$88K Sell
35
-7
-17% -$20.8K ﹤0.01% 6071
2019
Q1 		$170K Buy
42
+3
+8% +$11.6K ﹤0.01% 5605
2018
Q4 		$120K Buy
39
+9
+30% +$38.8K ﹤0.01% 5809
2018
Q3 		$177K Buy
30
+16
+114% +$60.9K ﹤0.01% 5548
2018
Q2 		$49K Buy
14
+9
+180% +$33K ﹤0.01% 6150
2018
Q1 		$22K Sell
5
-8
-62% -$37K ﹤0.01% 6353
2017
Q4 		$51K Buy
13
+12
+1,200% +$47.9K ﹤0.01% 6059
2017
Q3 		$5K Buy
+1
New +$4.46K ﹤0.01% 6722

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

Bank of America's FBRX Position: Q1 2026 in Review

Bank of America increased its Forte Biosciences (FBRX) stake by 444% in Q1 2026, buying an estimated $508K and bringing the position to 21,606 shares worth $560K. The position accounts for ﹤0.01% of the portfolio, ranked #4832.

Bank of America first reported a position in FBRX in Q3 2017 and has held it in 33 quarters since. 68 funds tracked by Wall St. Rank hold FBRX as of Q1 2026.

  • Bank of America held 21,606 shares of Forte Biosciences worth $560K as of Q1 2026.
  • Bank of America bought 17,634 Forte Biosciences shares in Q1 2026, an estimated $508K.
  • Forte Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4832 holding.
  • Bank of America first reported a position in Forte Biosciences in Q3 2017 and has held it in 33 quarters since.
  • 68 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.